Strategic Partnerships Target healthcare institutions with high NG/OG tube usage, such as NICUs and pediatrics departments, highlighting RightSpotpH as a safer, cost-effective alternative to X-ray confirmation to drive adoption in patient safety programs.

Clinical Adoption Leverage involvement in major conferences (SPN, ASPEN) to secure speaking slots, demos, and solid case studies that demonstrate reduced tube misplacement and streamlined workflows for clinicians.

Regulatory Advantage Position the product as FDA-cleared and CLIA-waived to facilitate rapid integration in hospital labs and bedside settings, reducing barriers to procurement and enabling faster pilots.

Cost of Care Emphasize potential cost savings from eliminating repeated X-rays and improving patient outcomes, appealing to hospital procurement and payer-related ROI discussions.

Growth Readiness Align outreach with small and mid-sized hospitals where revenue is under a million but needs innovative, scalable pH-based confirmation tech, offering scalable deployment and training packages.